Insulin resistance and hypertension: In vivo and in vitro insulin action in skeletal muscle in spontaneously hypertensive and Wistar Kyoto rats

American Journal of Hypertension

Volumn 10, Issue 10 I, 1997, Pages 1159-1164

  Swislocki, A L M ^a,b,c   Goodman, M N ^b   Khuu, D T ^a   Fann, K Y ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

Author keywords

Insulin resistance; Muscle glycogen synthesis; Spontaneously hypertensive rat

Indexed keywords

DEOXYGLUCOSE; GLUCOSE; GLYCOGEN; INSULIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEEDING; GASTROCNEMIUS MUSCLE; GLUCOSE TRANSPORT SYSTEM; GLYCOGEN LIVER LEVEL; GLYCOGEN SYNTHESIS; HYPERTENSION; INSULIN RESISTANCE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030702024     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(96)00209-9     Document Type: Article

References (34)

1. Swislocki ALM, Hoffman BB, Reaven GM: Insulin resistance, glucose intolerance, and hyperinsulinemia in patients with hypertension. Am J Hypertens 1989;2: 419-423.
2. Swislocki A: Insulin resistance and hypertension. Am J Med Sci 1990;300:104-115.
3. Swislocki A, Tsuzuki A: Insulin resistance and hypertension: glucose intolerance, hyperinsulinemia, and elevated free fatty acids in the lean Spontaneously Hypertensive Rat. Am J Med Sci 1993;306:282-286.
4. Mondon CE, Reaven GM: Evidence of abnormalities of insulin metabolism in rats with spontaneous hypertension. Metabolism 1988;37:303-305.
5. Hulman S, Falkner B, Chen YQ: Insulin resistance in the spontaneously hypertensive rat. Metabolism 1991; 40:359-361.
6. DeFronzo RA, Jacot E, Jequier E, et al: The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 1981;30:1000-1007.
7. Natali N, Santoro D, Palombo C, et al: Impaired insulin action on skeletal muscle metabolism in essential hypertension. Hypertension 1991;17:170-178.
8. Nadiv O, Cohen O, Zick Y: Defects of insulin's signal transduction in old rat livers. Endocrinology 1992;130: 1515-1524.
9. Rolband GC, Furth ED, Staddon JM, et al: Effects of age and adenosine in the modulation of insulin action on rat adipocyte metabolism. J Gerontol 1990;45:B174-B178.
10. Goodman MN, Dluz SM, McElaney MA, et al: Glucose uptake and insulin sensitivity in rat muscle: changes during 3-96 weeks of age. Am J Physiol 1983;244:E93-E100.
11. Good CA, Kramer H, Somogyi M: The determination of glycogen. J Biol Chem 1993;100:485-491.
12. Henriksen EJ, Bourey RE, Rodnick KJ, et al: Glucose transporter protein content and glucose transport capacity in rat skeletal muscles. Am J Physiol 1990;259: E593-E598.
13. Carlsen RC, Larson DB, Walsh DA: A fast-twitch oxidative glycolytic skeletal muscle with a robust inward calcium current. Can J Physiol Pharmacol 1985;63:958-965.
14. Maizels EZ, Ruderman NB, Goodman MN, et al: Effect of acetoacetate on glucose metabolism in the soleus and extensor digitorum longus muscles of the rat. Biochem J 1977;162:557-568.
15. Krebs HA, Henseleit K: Untersuchung uber die Harnstoffbildung im Tierkorper. Hoppe-Seyler's Z Physiol Chem 1932;210:33-66.
16. Stauffacher W, Renold AE: Effect of insulin in vivo on diaphragm and adipose tissue of obese mice. Am J Physiol 1969;216:98-105.
17. Richter EA, Garetto LP, Goodman MN, et al: Enhanced muscle glycogen metabolism after exercise: modulation by local factors. Am J Physiol 1984;E476-E482.
18. Young DA, Uhl JJ, Cartee GD, et al: Activation of glucose transport in muscle by prolonged exposure to insulin. J Biol Chem 1986;61:16049-16053.
19. Godfrey K: Statistics in practice. Comparing the means of several groups. N Engl J Med 1985;313:1450-1456.
20. Winer BJ: Statistical Principles in Experimental Design. McGraw-Hill, New York, 1971, pp 514-603.
21. Giaccari A, Rossetti L: Predominant role of gluconeogenesis in the hepatic glycogen repletion of diabetic rats. J Clin Invest 1992;89:36-45.
22. Holness MJ, Howard RM, Sugden MC. Glucose utilization and disposition by skeletal muscle during unrestricted feeding. Biochem J 1992;286:395-398.
23. Goodman MN, Dietrich R, Luu P: Formation of gluconeogenic precursors in rat skeletal muscle during fasted-refed transition. Am J Physiol 1990;259:E513-E516.
24. Rossetti L, Hu M: Skeletal muscle glycogenolysis is more sensitive to insulin than is glucose transport/ phosphorylation. J Clin Invest 1993;92:2963-2974.
25. Vaag A, Henriksen JE, Beck-Nielsen H: Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1992;89:782-788.
26. Damsbo P, Vaag A, Hother-Nielsen O, Beck-Nielsen H: Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1991;34:239-245.
27. Kelley DE, Mandarine LJ: Hyperglycemia normalizes insulin-stimulated skeletal muscle glucose oxidation and storage in non-insulin-dependent diabetes mellitus. J Clin Invest 1990;86:1999-2007.
28. Johnson AB, Argyraki M, Thow JC, et al: Effects of intensive dietary treatment on insulin-stimulated skeletal muscle glycogen synthase activation and insulin secretion in newly presenting type 2 diabetic patients. Diabetic Med 1990;7:420-428.
29. Thorburn AW, Gumbiner B, Bulacan F, et al: Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin-dependent diabetes mellitus. J Clin Invest 1991;87:489-495.
30. Farrace S, Frontoni S, Gambardella S, et al: Glycogen synthase activity in two rat models of hypertension. Am J Hypertens 1995;8:949-953.
31. Baron AD, Brechtel G: Insulin differentially regulates systematic and skeletal muscle vascular resistance. Am J Physiol 1993;265:E61-E67.
32. Swislocki A, Eason T: Glucose tolerance and blood pressure are improved in the Spontaneously Hypertensive Rat by ethyl-2-(6-(4-chlorophenoxy)-hexyl)ox-irane-2-carboxylate (etomoxir), an inhibitor of fatty acid oxidation. Am J Hypertens, 1994;7:739-744.
33. Watlington CO, Kramer LB, Schuetz, et al: Corticosterone 6-β-hydroxylation correlates with blood pressure in spontaneously hypertensive rats. Am J Physiol 1992; 262:F927-F931.
34. Gumbiner B, Thorburn AW, Ditzler TM, et al: Role of impaired intracellular glucose metabolism in the insulin resistance of aging. Metabolism 1992;41:1115-1121.